myelodysplastic syndrome patients are subjects of advanced age, vulnerable and frail, whose outcome is heavily influenced by pre-existing comorbidities worsening the hematologic condition
SARS-CoV-2 in myelodysplastic syndromes: A snapshot from early Italian experience
Bernardi M.;Mancini S.;Musto P.;
2020-01-01
Abstract
myelodysplastic syndrome patients are subjects of advanced age, vulnerable and frail, whose outcome is heavily influenced by pre-existing comorbidities worsening the hematologic conditionFile in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
SARS_CoV_2_in_Myelodysplastic_Syndromes__A.16.pdf
accesso aperto
Descrizione: articolo principale
Tipologia:
Documento in Versione Editoriale
Licenza:
Creative commons
Dimensione
235.76 kB
Formato
Adobe PDF
|
235.76 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
